Cobratoxin

From WikiMD's WELLNESSPEDIA

File:PDB 1ctx EBI.jpg
PDB 1ctx EBI

Cobratoxin is a potent neurotoxin derived from the venom of the Naja genus, commonly known as cobras. It is a member of the three-finger toxin family, which is characterized by its unique three-fingered structure. Cobratoxin is known for its ability to bind to nicotinic acetylcholine receptors, leading to paralysis and potentially death.

Structure and Function[edit]

Cobratoxin is a polypeptide consisting of 71 amino acids. Its structure is stabilized by four disulfide bridges, which contribute to its high stability and resistance to enzymatic degradation. The three-finger structure allows it to interact specifically with the nicotinic acetylcholine receptors at the neuromuscular junction.

Mechanism of Action[edit]

Cobratoxin exerts its effects by binding to the nicotinic acetylcholine receptors on the postsynaptic membrane of the neuromuscular junction. This binding inhibits the action of acetylcholine, a neurotransmitter responsible for muscle contraction. As a result, the toxin causes flaccid paralysis by preventing the transmission of nerve impulses to the muscles.

Medical Research and Applications[edit]

Research into cobratoxin has revealed potential therapeutic applications, particularly in the field of pain management and neurological disorders. Studies have shown that cobratoxin can act as an analgesic by modulating pain pathways. Additionally, its ability to target specific receptors makes it a candidate for the development of drugs for conditions such as myasthenia gravis and epilepsy.

Toxicity and Treatment[edit]

Cobratoxin is highly toxic, and envenomation by a cobra can be fatal if not treated promptly. Symptoms of cobratoxin poisoning include muscle weakness, respiratory failure, and paralysis. Treatment typically involves the administration of antivenom, which contains antibodies that neutralize the toxin. Supportive care, such as mechanical ventilation, may also be necessary in severe cases.

Related Pages[edit]

Categories[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.